United Drug acquires pharma contractors for $33M; Numoda will handle PhI for Proteonomix's liver drug;

> United Drug has bought pharma risk-management contractor Drug Safety Alliance for $21 million and market-access firm Synopia for $12 million. News

> Numoda has signed up to conduct Phase I trials for Proteonomix's UMK-121 for end-stage liver disease. More

> Harlan Laboratories is expanding its agrochemicals and global pathology units, appointing new general managers for each. Story

> Icon ($ICLR) is expanding some of its labs in the U.S. and U.K., adding space for dedicated immunoassay development. Article

> WuXi PharmaTech ($WX) has entered a drug discovery pact with Open Monoclonal Technology, looking to discover antibodies using OMT's rat models. Report

> CMIC got qualification for three new development suites in New Jersey, a development the company says will help speed up drug development. Item

 

 

Suggested Articles

Major CRO player Pharmaceutical Product Development is set to go back on the public markets after announcing its IPO plans.

Dubbed “Project Nightingale,” the efforts were announced amid concerns and federal inquiries into the data’s safekeeping and patient consent for use.

Independent site management organization Panthera Biopartners has kick-started its first clinical trial in the U.K.